Enhanced cytotoxicity of saporin by polyamidoamine dendrimer conjugation and photochemical internalization

Journal of Biomedical Materials Research - Part A

Volumn 87, Issue 1, 2008, Pages 147-155

  Lai, Ping Shan ^a   Pai, Chin Ling ^a   Peng, Cheng Liang ^b   Shieh, Ming Jium ^b,c   Berg, Kristian ^d   Lou, Pei Jen ^c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer therapy; Photochemical internalization; Polyamidoamine dendrimer; Ribosome inactivating protein; Saporin

Indexed keywords

CELL MEMBRANES; COMPUTER PERIPHERAL EQUIPMENT; TECHNOLOGY;

CANCER THERAPIES; CANCER THERAPY; CELLULAR UPTAKE; CYTOSOL; CYTOSOLIC; CYTOTOXIC EFFECTS; MEMBRANE BINDING; ORDER-OF MAGNITUDES; PAMAM DENDRIMER; PHOTOCHEMICAL INTERNALIZATION; POLYAMIDOAMINE DENDRIMER; POLYMER CONJUGATION; POTENTIAL BARRIERS; RIBOSOME-INACTIVATING PROTEIN; RIBOSOME-INACTIVATING PROTEINS; SAPORIN; TOXIN INTERNALIZATION; TUMOR TARGETING;

INTERFACES (COMPUTER);

DENDRIMER; POLYAMIDOAMINE; RIBOSOME INACTIVATING PROTEIN; SAPORIN;

ARTICLE; CANCER THERAPY; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; ENDOCYTOSIS; HUMAN; HUMAN CELL; PHOTOCHEMICAL INTERNALIZATION; PHOTODYNAMIC THERAPY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CYTOSOL; DENDRIMERS; DRUG CARRIERS; ENDOCYTOSIS; HUMANS; MICROSCOPY, CONFOCAL; NYLONS; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOSOME INACTIVATING PROTEINS, TYPE 1;

EID: 51849151811     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31760     Document Type: Article

References (49)

1. Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes - The site and the characteristics of the modification in 28-S ribosomal-RNA caused by the toxins. J Biol Chem 1987;262:5908-5912.
2. Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants. Biochim Biophys Acta 1993;1154:237-282.
3. Wang P, Tumer NE. Pokeweed antiviral protein cleaves double-stranded supercoiled DNA using the same active site required to depurinate rRNA. Nucleic Acids Res 1999;27:1900-1905.
4. Ferreras JM, Barbieri L, Girbes T, Battelli MG, Rojo MA, Arias FJ, Rocher MA, Soriano F, Mendez E, Stirpe F. Distribution and properties of major ribosome-inactivating proteins (28-S ribosomal-RNA N-glycosidases) of the plant Saponaria officinalis L (caryophyllaceae). Biochim Biophys Acta 1993;1216:31-12.
5. Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Br J Cancer 2001;84:571-578.
6. Wu M. Enhancement of immunotoxin activity using chemical and biological reagents. Br J Cancer 1997;75:1347-1355.
7. Barth RF, Yang WL, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Cancer Res 2002;62:3159-3166.
8. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today 2001;6:427-136.
9. Patri AK, Majoros IJ, Baker JR. Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 2002;6:466-171.
10. Tomalia DA, Naylor AM, Goddard WA. Starburst dendrimers - Molecular-level control of size, shape, surface-chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed 1990;29:138-175.
11. Bielinska A, Kukowska L, Johnson J, Tomalia DA, Baker JR. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res 1996;24:2176-2182.
12. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000;65:271-284.
13. Malik N, Evagorou EG, Duncan R. Dendrimer-platinate: A novel approach to cancer chemotherapy. Anticancer Drugs 1999;10:767-776.
14. Berg K, Selbo PK, Prasmickaite L, Tjelle TE, Sandvig K, Moan D, Gaudernack G, Fodstad O, Kjolsrud S, Anholt H, Rodal GH, Rodal SK, Hogset A. Photochemical internalization: A novel technology for delivery of macromolecules into cytosol. Cancer Res 1999;59:1180-1183.
15. Prasmickaite L, Hogset A, Selbo PK, Engesaeter BO, Helium M, Berg K. Photochemical disruption of endocytic vesicles before delivery of drugs: A new strategy for cancer therapy. Br J Cancer 2002;86:652-657.
16. Selbo PK, Sandvig K, Kirveliene V, Berg K. Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization. Biochim Biophys Acta 2000;1475:307-313.
17. Engesaeter BO, Bonsted A, Berg K, Hogset A, Engebraten O, Fodstad O, Curiel DT, Maelandsmo GM. PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles. Cancer Gene Ther 2005;12:439-148.
18. Folini M, Berg K, Millo E, Villa R, Prasmickaite L, Daidone MG, Benatti U, Zaffaroni N. Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. Cancer Res 2003;63:3490-3494.
19. Selbo PK, Sivam G, Fodstad O, Sandvig K, Berg K. Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin. Int J Cancer 2000;87:853-859.
20. Lou PJ, Lai PS, Shieh MJ, MacRobert AJ, Berg K, Bown SG. Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization. Int J Cancer 2006;119:2692-2698.
21. Kamata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S, Kuroki T. Growth-inhibitory effects of epidermal growth-factor and overexpression of its receptors on human squamous-cell carcinomas in culture. Cancer Res 1986;46:1648-1653.
22. Ko JY, Lee TC, Hsiao CF, Lin GL, Yen SH, Chen KY, Hsiung CA, Chen PJ, Hsu MM, Jou YS. Definition of three minimal deleted regions comprehensive allelotyping and mutational of FHIT, p16(INK4a), and p19(ARF) genes in nasopharyngeal carcinoma. Cancer 2002;94:1987-1996.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival - Application to proliferation and cyto-toxicity assays. J Immunol Methods 1983;65:55-63.
24. Chou TC, Talalay P. Quantitative-analysis of dose-effect relationships - The combined effects of multiple-drugs or enzyme-inhibitors. Adv Enzyme Regul 1984;22:27-55.
25. Demoy M, Minko T, Kopeckova P, Kopecek J. Time- and concentration- dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release 2000;69:185-196.
26. Minko T, Kopeckova P, Kopecek J. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer 2000;86:108-117.
27. Minko T, Kopeckova P, Kopecek J. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Pharm Res 1999;16:986-996.
28. Arpicco S, Dosio F, Bolognesi A, Lubelli C, Brusa P, Stella B, Ceruti M, Cattel L. Novel poly(ethylene glycol) derivatives for preparation of ribosome-inactivating protein conjugates. Bioconjugate Chem 2002;13:757-765.
29. Wiley RG, Oeltmann TN, Lappi DA. Immunolesioning - Selective destruction of neurons using immunotoxin to rat NGF Receptor. Brain Res 1991;562:149-153.
30. Pasqualucci L, Wasik M, Teicher BA, Flenghi L, Bolognesi A, Stirpe F, Polito L, Falini B, Kadin ME. Antitumor-activity of anti-CD30 immunotoxin (Ber-H2 saporin) in-vitro and in severe combined immunodeficiency disease mice xenografted with human CD30(+) anaplastic large-cell lymphoma. Blood 1995;85:2139-2146.
31. Battelli MG, Buonamici L, Bolognesi A, Stirpe F. In-vivo and in-vitro uptake of an anti-Cd30/saporin immunotoxin by rat-liver parenchymal and nonparenchymal cells. Hepatology 1994;20:940-947.
32. Blasi F, Vassalli JD, Dano K. Urokinase-type plasminogen-activator - Proenzyme, receptor, and inhibitors. J Cell Biol 1987;104:801-804.
33. Ippoliti R, Lendaro E, Benedetti PA, Torrisi MR, Belleudi F, Carpani D, Soria MR, Fabbrini MS. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: An unusual internalization mechanism. FASEB J 2000;14:1335-1144.
34. Fabbrini MS, Carpani D, BelloRivero I, Soria MR. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: Internalization is toxin mediated. FASEB J 1997;11:1169-1176.
35. Provoda CJ, Stier EM, Lee KD. Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin. J Biol Chem 2003;278:35102-35108.
36. Poma A, Cesare P, Marcozzi G, Spano L. Nuclear damage induced by liposomes containing FITC-labelled saporin on human melanoma cells in vitro. J Liposome Res 2001;11:91-102.
37. Mcintosh DP, Heath TD. Liposome-mediated delivery of ribosome inactivating proteins to cells-in vitro. Biochim Biophys Acta 1982;690:224-230.
38. Dosio F, Brusa P, Delprino L, Grosa G, Ceruti M, Cattel L. A new approach in the synthesis of immunotoxins - Ribosome-inactivating protein noncovalently bound to monoclonal-antibody. J Pharm Sci 1994;83:206-211.
39. Lambert JM, Senter PD, Yauyoung A, Blattler WA, Goldmacher VS. Purified immunotoxins that are reactive with human lymphoid-cells - Monoclonal-antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins. J Biol Chem 1985;260:2035-2041.
40. Thorpe PE, Brown ANF, Ross WCJ, Cumber AJ, Detre SI, Edwards DC, Davies AJS, Stirpe F. Cyto-toxicity acquired by conjugation of an anti-Thy1.1 monoclonal-antibody and the ribosome-inactivating protein, gelonin. Eur J Biochem 1981;116:447-154.
41. Kukowska-Latallo JF, Candido KA, Cao ZY, Nigavekar SS, Majoras IJ, Thomas TP, Balogh LP, Khan MK, Baker JR. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 2005;65:5317-5324.
42. Landers JJ, Cao ZY, Lee I, Piehler LT, Myc PP, Myc A, Hamouda T, Galecki AT, Baker JR. Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers. J Infect Dis 2002;186:1222-1230.
43. Chandrasekar D, Sistla R, Ahmad FJ, Khar RK, Diwan PV. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials 2007;28:504-512.
44. Kichler A, Leborgne C, Coeytaux E, Danos O. Polyethylenimine-mediated gene delivery: A mechanistic study. J Gene Med 2001;3:135-144.
45. Sonawane ND, Szoka FC, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003;278:44826-14831.
46. Delius M, Adams G. Shock wave permeabilization with ribosome inactivating proteins: A new approach to tumor therapy. Cancer Res 1999;59:5227-5232.
47. Kodama T, Doukas AG, Hamblin MR. Delivery of ribosome-inactivating protein toxin into cancer cells with shock waves. Cancer Lett 2003;189:69-75.
48. Bagga S, Seth D, Batra JK. The cytotoxic activity of ribosome- inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities. J Biol Chem 2003;278:4813-1820.
49. Jans DA, Hubner S. Regulation of protein transport to the nucleus: Central role of phosphorylation. Physiol Rev 1996;76:651-685.